{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-195950","form_type":"8-K","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.805242+00:00","generated_at":"2026-05-31T11:39:32.114059+00:00","sec_items":["8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Catalyst Q2 revenue $122.7M (+23% YoY); GAAP EPS $0.33, non-GAAP $0.56; guides upper end of $455-475M","bullets":["Total Q2 2024 revenue $122.7M, up 23.3% YoY; FIRDAPSE $77.4M (+19.2%), FYCOMPA $36.5M (+5.7%), AGAMREE $8.7M (new launch).","GAAP net income $40.8M ($0.33 diluted); non-GAAP net income $69.6M ($0.56 diluted), up 15.3% YoY.","Cash and equivalents $375.7M at June 30, 2024, up from $137.6M at Dec 31, 2023 (+173%).","Reaffirms 2024 total revenue guidance of $455-$475M; expects results in upper half of range.","Announced license agreement for AGAMREE in Canada to expand rare orphan portfolio."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-195950","json":"https://secwatch.observer/filing/0001193125-24-195950.json","markdown":"https://secwatch.observer/filing/0001193125-24-195950.md","text":"https://secwatch.observer/filing/0001193125-24-195950.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312524195950/0001193125-24-195950-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312524195950/d873312d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:39:32.114059+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}